TGINSIGHT SIMILAR POSTS
Изворен канал @pythonotes · Post #183 · 23 ное.
Python + bash Если вам часто требуется запускать shell команды из Python-кода, какой способ вы используете? Самый низкоуровневый это функция os.system(), либо os.popen(). Рекомендованный способ это subprocess.call(). Но это всё еще достаточно неудобно. Советую обратить своё внимание на очень крутую библиотеку sh. Что она умеет? 🔸 удобный синтаксис вызова команд как функций # os import os os.system("tar cvf demo.tar ~/") # subprocess import subprocess subprocess.call(['tar', 'cvf', 'demo.tar', '~/']) # sh import sh sh.tar('cvf', 'demo.tar', "~/") 🔸 простое создание функции-алиаса для длинной команды fn = sh.lsof.bake('-i', '-P', '-n') output = sh.grep(fn(), 'LISTEN') в этом примере также задействован пайпинг 🔸 удобный вызов команд от sudo with sh.contrib.sudo: print(ls("/root")) Такой запрос спросит пароль. Чтобы это работало нужно соответствующим способом настроить юзера. А вот вариант с вводом пароля через код. password = "secret" sudo = sh.sudo.bake("-S", _in=password+"\n") print(sudo.ls("/root")) Это не все фишки. Больше интересных примеров смотрите в документации. Специально для Windows💀 юзеров #libs#linux
Пребарај: #biotechnology
@venturevillagewall · Post #3500 · 19.12.2024 г., 13:59
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 20.12.2024 г., 09:33
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 21.12.2024 г., 10:22
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 20.12.2024 г., 09:34
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 20.12.2024 г., 09:32
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 21.12.2024 г., 10:22
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences